Popa has more than 20 years of experience in communications, including 7 years dedicated to the pharmaceutical industry. Her work has spanned multiple therapeutic areas, including cardiology, neurology, and orphan diseases.
Bonello has more than 30 years of experience, including 15 years in the clinical research industry.
Bristol Myers Squibb said on Wednesday evening its CEO Giovanni Caforio would step down in November and will be replaced by current Chief Commercialization Officer Chris Boerner, as the drugmaker contends with increasing generic competition for its top-selling drugs.
The three executive appointments bolster leadership across strategy, medical, and APAC.
Garde has more than 30 years’ experience in healthcare communication and business operations.
The promotion elevates Irish and Evans to the highest level of leadership at Peregrine.
Generic drugmaker Hikma Pharmaceuticals Plc. said on Wednesday Riad Mishlawi, president of the group’s injectables business, will become its chief executive officer, effective Sept. 1.
These new additions to Onyx Health’s Account Management and Creative teams, enhances their capacity and expertise, allowing them to continue to effectively meet client needs and offer an expansive range of marketing and communication services.
David joins CultHealth with close to 15 years of diverse marketing and creative experience in life sciences and has been closely involved with blockbuster launches, startup acceleration, productization, the genomics revolution, and the advent of connected care.
His primary responsibilities are accelerating the growth and profitability of AbelsonTaylor’s production group and providing full-service production capabilities to a wide range of clients.